FDA Adverse Event Injury Summary report: N

MD HYBRID GLENOID BASE 4MM

MDR report key: 14206881 · Received April 26, 2022

Report

Report Number
0001825034-2022-00801
Event Type
Injury
Date Received
April 26, 2022
Date of Event
March 15, 2022
Report Date
August 3, 2022
Manufacturer
ZIMMER BIOMET, INC.
Product Code
MBF
PMA / PMN Number
K193038
Removal / Correction Number
NI
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034-2022-00979. CONCOMITANT MEDICAL PRODUCTS: ITEM# 113042; LOT# 247180, ITEM# PT-113950; LOT# 889150, ITEM# 118001; LOT# 727670, ITEM# US-115736; LOT# 162430. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS THE PRODUCT LOCATION IS UNKNOWN. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. UPON RECEIPT OF ADDITIONAL INFORMATION, IT WAS DETERMINED THIS PRODUCT AND EVENT HAS ALREADY BEEN REPORTED UNDER MEDWATCH# 0001825034-2018-02337. THIS REPORT SHOULD BE VOIDED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WAS REVISED APPROXIMATELY EIGHT (8) YEARS POST-IMPLANTATION DUE PAIN AND INSTABILITY. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1531014 MD HYBRID GLENOID BASE 4MM PROSTHESIS, SHOULDER MBF ZIMMER BIOMET, INC. NI 010160

Patients

Seq Age Sex Outcome Treatment
1 72 YR Male Required Intervention| H